JohnCLamattinaMD
General Surgery • Chicago, ILTransplantation
Assistant Professor, Surgery, University of Maryland School of Medicine
Are you Dr. Lamattina?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200
Summary
- Dr. John Lamattina, MD is a general surgeon in Chicago, Illinois. He is currently licensed to practice medicine in Illinois, Alaska, and West Virginia. He is affiliated with University of Chicago Medical Center and is an Assistant Professor at University of Maryland School of Medicine.
Education & Training
Massachusetts General HospitalResidency, Surgery, 2003 - 2008
Harvard Medical SchoolClass of 2003
Certifications & Licensure
IL State Medical License 2020 - 2026
WI State Medical License 2008 - 2025
AK State Medical License 2019 - 2024
MD State Medical License 2010 - 2022
WV State Medical License 2014 - 2022- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Publications & Presentations
PubMed
- 5 citationsMultiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15.Sara Brown, Yulia Savva, Rolf N. Barth, John C. LaMattina, Paul J. Thuluvath
Transplantation. 2020-04-01 - 9 citationsSequential kidney-liver transplantation from the same living donor for lecithin cholesterol acyl transferase deficiency.Sarwat B. Ahmad, Michael Miller, Steven I. Hanish, Stephen T. Bartlett, William R. Hutson
Clinical Transplantation. 2016-10-01 - 49 citationsSelection of Patients for Initial Clinical Trials of Solid Organ Xenotransplantation.David K. C. Cooper, Martin Wijkstrom, Sundaram Hariharan, Joshua L. Chan, Avneesh K. Singh
Transplantation. 2017-07-01
Authored Content
- Pfizer Should Be Wary About Covid-19 Vaccine Price HikesFebruary 2021
Press Mentions
Vedanta Biosciences Closes $50 Million Financing to Advance Microbiome TherapeuticsJune 6th, 2016- Vedanta Biosciences Announces License Agreement with RIKEN and Other Japanese Institutions for New Immune Boosting Microbiome TechnologyApril 14th, 2016
- Vedanta Biosciences Appoints New Chief Scientific Officer and Expands to New FacilityMarch 16th, 2016
Professional Memberships
- Member
